{
  "slug": "melanotan-2",
  "name": "Melanotan-2",
  "aliases": ["MT-2", "MT-II", "Melanotan II"],
  "category_tags": ["skin", "libido"],
  "typical_route": ["subQ"],
  "overview": "Melanotan-2 is a synthetic peptide analog of alpha-melanocyte stimulating hormone. It is often discussed for its effects on skin pigmentation and libido, though it is not approved by major regulatory agencies and safety data is limited.",
  "what_people_seek": [
    "Skin tanning without UV exposure",
    "Libido enhancement",
    "Appetite suppression (secondary effect)",
    "Sexual function support"
  ],
  "evidence_level": "Preliminary",
  "risk_level": "High",
  "side_effects_common": [
    "Nausea (especially with initial doses)",
    "Flushing",
    "Facial darkening or uneven pigmentation",
    "Spontaneous erections (in males)",
    "Increased skin moles and freckles",
    "Fatigue",
    "Loss of appetite"
  ],
  "who_should_avoid": [
    "Pregnant or breastfeeding individuals",
    "People with a personal or family history of melanoma or other skin cancers",
    "Those with cardiovascular conditions",
    "Individuals with uncontrolled high blood pressure",
    "Anyone with numerous moles or atypical moles (requires dermatology evaluation)",
    "Those taking medications affecting skin or cardiovascular system without medical review"
  ],
  "interactions_notes": "May interact with medications affecting blood pressure or cardiovascular function. Risk profile is poorly characterized. Consultation with healthcare provider is critical.",
  "dosing_ranges_literature": "Anecdotal protocols often cite 0.25-1 mg per dose, with 'loading' phases followed by maintenance. No formal clinical dosing exists. Use is not medically endorsed.",
  "reconstitution": {
    "vial_total_mg": 10,
    "common_diluents_ml": [1, 2],
    "example_doses_mg": [0.25, 0.5, 1]
  },
  "storage_notes": "Store lyophilized powder refrigerated or frozen. After reconstitution, refrigerate and use promptly per supplier guidance.",
  "references": [
    {
      "id": "ref1",
      "title": "Melanocortin Receptor Agonists: Risks and Unknowns",
      "source": "Review",
      "year": 2020,
      "url": "https://example.com/melanotan-risks",
      "note": "Highlights lack of regulatory approval and safety concerns including potential link to skin cancer."
    },
    {
      "id": "ref2",
      "title": "Unregulated Tanning Peptides: Public Health Perspective",
      "source": "Other",
      "year": 2021,
      "url": "https://example.com/tanning-peptides",
      "note": "Discusses unmonitored distribution and potential harms of non-approved tanning agents."
    }
  ],
  "last_reviewed": "2025-11-02"
}
